Search Within

GDMT, Medicine

Formats
  1. Journal Article (918)
  2. Meeting Abstract (825)
  3. Review (46)
  4. Book Section (38)
  5. Editorial (28)
  6. Guidelines (18)
  7. Correspondence (7)
  8. Research Letter (1)
Groups
  1. Gynecology Disease Management Team (1881)
  2. Department of Medicine (1872)
  3. Solid Tumor Oncology Division (1870)
  4. Gynecologic Medicine Service (1830)
  5. Surgery (577)
  6. GDMT, Surgery (462)

More Groups

People
  1. Carol Aghajanian (608)
  2. Martee Hensley (289)
  3. Nadeem Abu-Rustum (277)
  4. Roisin O'Cearbhaill (271)
  5. Vicky Makker (263)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (44)
  2. 2024 (159)
  3. 2023 (165)
  4. 2022 (196)
  5. 2021 (146)
  6. 2020 (173)

More Years

Publications
  1. Gynecologic Oncology (416)
  2. Journal of Clinical Oncology (414)
  3. International Journal of Gynecological Cancer (148)
  4. Annals of Oncology (106)
  5. Clinical Cancer Research (61)
  6. Cancer (37)

More Publications

Publishers
  1. Elsevier Inc. (495)
  2. American Society of Clinical Oncology (445)
  3. Lippincott Williams & Wilkins (173)
  4. American Association for Cancer Research (136)
  5. Oxford University Press (128)
  6. Nature Publishing Group (71)

More Publishers

Results (1881)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Germline drivers of gynecologic carcinosarcoma
    Meeting Abstract

    Sia, T.; Birsoy, O.; Kemel, Y.; Maio, A.; Salo-Mullen, E.; Sheehan, M.; Hensley, M.; Rubinstein, M.; Makker, V.; Grisham, R.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Mesonephric and mesonephric-like adenocarcinomas of gynecologic origin: A single-center experience with molecular characterization, treatment, and oncologic outcomes
    Meeting Abstract

    Praiss, A.; Park, K.; Zhou, Q.; White, C.; Iasonos, A.; Zivanovic, O.; Abu-Rustum, N.; Weigelt, B.; Aghajanian, C.; Grisham, R.
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • ENGOT-EN20/GOG-3083/XPORT-EC-042 A phase 3, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients (pts) with P53 wild-type, advanced or recurrent endometrial carcinoma
    Meeting Abstract

    Makker, V.; Vergote, I.; Mirza, M.; Coleman, R.; Fidalgo, J. A. P.; Monk, B.; Valabrega, G.; Slomovitz, B.; van Gorp, T.; Moore, K.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Characterization of tumor response with lenvatinib plus pembrolizumab in study 309/KEYNOTE-775
    Meeting Abstract

    Makker, V.; Lorusso, D.; Moore, R.; Miller, D.; Mackay, H.; Santin, A.; Ushijima, K.; Kim, Y. M.; Sanli, U.; Yonemori, K.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Evolution of intra-tumoral and peripheral pro-tumorigenic response during primary cytoreductive surgery for ovarian cancer
    Meeting Abstract

    Praiss, A.; Moukarzel, L.; Zhu, Y.; Derakhshan, F.; Hoang, T.; Pesci, G.; Green, H.; Hanlon, E.; Gardner, G.; Roche, K. L.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Real-world outcomes and adverse events when using combination lenvatinib and pembrolizumab for the treatment of recurrent uterine cancer
    Meeting Abstract

    Zammarrelli, W.; Ma, W.; Espino, K.; Yeoshoua, E.; Ehmann, S.; Zhou, Q.; Iasonos, A.; Abu-Rustum, N.; Aghajanian, C.; Green, A.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • My individualized risk reduction for ovarian cancer (MIRROR): Development of a patient decision aid for risk-reducing surgery in hereditary risk for ovarian cancer
    Meeting Abstract

    Feinberg, J.; Gordhandas, S.; Austria, M.; Carlsson, S.; Abu-Rustum, N.; Liu, Y.; Roche, K. L.
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Leave it in the past: Primary treatment modality for high-grade epithelial ovarian cancer does not affect secondary cytoreduction outcomes
    Meeting Abstract

    Manning-Geist, B.; Sia, T.; Ehmann, S.; Luardo, C.; Praiss, A.; Lavery, J.; Iasonos, A.; Sonoda, Y.; Grisham, R.; Zivanovic, O.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • ADAGIO: A phase IIb, open-label, single-arm, multicenter study assessing the efficacy and safety of adavosertib (AZD1775) as treatment for recurrent or persistent uterine serous carcinoma
    Meeting Abstract

    Liu, J.; Colombo, N.; Oza, A.; Frenel, J. S.; Corr, B.; Rubinstein, M.; Nevadunsky, N.; Lheureux, S.; Gaba, L.; Cortijo, L. G.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Oncolytic immunotherapy with recombinant Newcastle disease virus-encoding interleukin-12 in ovarian cancer mouse models
    Meeting Abstract

    Kahn, R.; Green, H.; Pesci, G.; Burman, B.; Praiss, A.; Ozsoy, M.; Brodeur, M.; Bhaloo, S. I.; Abu-Rustum, N.; Chi, D.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save